Related Experiment Video
Updated: Feb 24, 2026

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
Published on: July 11, 2015
Protective immunity against tuberculosis: what does it look like and how do we find it?
1Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY 14853, United States.
Developing tuberculosis vaccines requires understanding immune responses. Microbial reporters can reveal how host cells affect bacterial growth, aiding vaccine and therapeutic development for tuberculosis control.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Tuberculosis (TB) vaccine development is hindered by a lack of reliable immune protection markers.
- Limited understanding exists regarding immune mechanisms controlling TB disease progression versus containment.
Purpose of the Study:
- To discuss the utility of microbial readouts of bacterial fitness.
- To investigate host immune environments and identify cell subsets influencing bacterial growth.
- To highlight the importance of this knowledge for TB vaccine and therapeutic strategies.
Main Methods:
- Utilizing microbial reporters to assess bacterial fitness within host environments.
- Probing host immune cell subsets for their role in promoting or controlling bacterial growth.
Main Results:
- Bacterial reporters offer a novel approach to study host-pathogen interactions in TB.
- Identification of specific host cell subsets that either support or inhibit Mycobacterium tuberculosis growth.
Conclusions:
- Microbial readouts are crucial for understanding immune mechanisms underlying TB disease outcomes.
- This approach is vital for developing effective tuberculosis vaccines and immune-modulatory therapies.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...